Wikidata

(Q40505651)

English

Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study

scientific article

In more languages

Statements

title
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017
author name string
Miguel A Sanz
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017
Arancha Bermúdez
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017
Montserrat Rovira
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017
Juan Besalduch
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017
Maria-Jesus Pascual
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017
Gonzalo Nocea
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017
César Sanz-Rodríguez
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017
COSTINE Study Group
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017
publication date
1 May 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017
page(s)
645-655
1 reference
stated in
Europe PubMed Central
PubMed ID
15969864
retrieved
21 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40505651&oldid=1899446792"